These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

855 related articles for article (PubMed ID: 33762537)

  • 1. An Ace Up Our Sleeves: The COVID-19 Vaccine Rollout Revealed Our Strengths and Our Neglected Public Health Infrastructure.
    Pierce HH
    J Public Health Manag Pract; 2021 May-Jun 01; 27(3):223-225. PubMed ID: 33762537
    [No Abstract]   [Full Text] [Related]  

  • 2. Alternative Dose Allocation Strategies to Increase Benefits From Constrained COVID-19 Vaccine Supply.
    Tuite AR; Zhu L; Fisman DN; Salomon JA
    Ann Intern Med; 2021 Apr; 174(4):570-572. PubMed ID: 33395334
    [No Abstract]   [Full Text] [Related]  

  • 3. Audio Interview: Protecting the Immunosuppressed against Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 May; 384(21):e88. PubMed ID: 34042395
    [No Abstract]   [Full Text] [Related]  

  • 4. Maintaining a Focus on Health Equity During the COVID-19 Vaccine Rollout.
    Martin EG; Birkhead GS; Holtgrave DR
    J Public Health Manag Pract; 2021 May-Jun 01; 27(3):226-228. PubMed ID: 33762538
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 vaccine intentions in Australia.
    Pickles K; Copp T; Dodd RH; Cvejic E; Seale H; Steffens MS; Meyerowitz-Katz G; Bonner C; McCaffery K
    Lancet Infect Dis; 2021 Dec; 21(12):1627-1628. PubMed ID: 34838219
    [No Abstract]   [Full Text] [Related]  

  • 6. Delayed Second Dose versus Standard Regimen for Covid-19 Vaccination.
    Kadire SR; Wachter RM; Lurie N
    N Engl J Med; 2021 Mar; 384(9):e28. PubMed ID: 33596347
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead.
    Massinga Loembé M; Nkengasong JN
    Immunity; 2021 Jul; 54(7):1353-1362. PubMed ID: 34260880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The story behind Chile's rapid rollout of COVID-19 vaccination.
    Aguilera X; Mundt AP; Araos R; Weitzel T
    Travel Med Infect Dis; 2021; 42():102092. PubMed ID: 34051353
    [No Abstract]   [Full Text] [Related]  

  • 9. A Public Health COVID-19 Vaccination Strategy to Maximize the Health Gains for Every Single Vaccine Dose.
    Barnabas RV; Wald A
    Ann Intern Med; 2021 Apr; 174(4):552-553. PubMed ID: 33395339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying and Benchmarking Disparities in COVID-19 Vaccination Rates by Race and Ethnicity.
    Reitsma MB; Goldhaber-Fiebert JD; Salomon JA
    JAMA Netw Open; 2021 Oct; 4(10):e2130343. PubMed ID: 34668949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
    Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
    Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What constitutes success in the roll-out of COVID-19 vaccines?
    Smith MJ
    Lancet; 2021 Jul; 398(10295):115-116. PubMed ID: 34181882
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 vaccine uptake in patients with psychiatric disorders admitted to or residing in a university psychiatric hospital.
    Mazereel V; Vanbrabant T; Desplenter F; De Hert M
    Lancet Psychiatry; 2021 Oct; 8(10):860-861. PubMed ID: 34416185
    [No Abstract]   [Full Text] [Related]  

  • 14. Faith-Based Organizations and SARS-CoV-2 Vaccination: Challenges and Recommendations.
    Levin J; Idler EL; VanderWeele TJ
    Public Health Rep; 2022; 137(1):11-16. PubMed ID: 34694939
    [No Abstract]   [Full Text] [Related]  

  • 15. How COVID vaccines shaped 2021 in eight powerful charts.
    Mallapaty S; Callaway E; Kozlov M; Ledford H; Pickrell J; Van Noorden R
    Nature; 2021 Dec; 600(7890):580-583. PubMed ID: 34916666
    [No Abstract]   [Full Text] [Related]  

  • 16. Persuading US White evangelicals to vaccinate for COVID-19: Testing message effectiveness in fall 2020 and spring 2021.
    Bokemper SE; Gerber AS; Omer SB; Huber GA
    Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34845032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Scientists' Collective 10-point proposal for equitable and timeous access to COVID-19 vaccine in South Africa.
    Gray G; Van der Heever A; Madhi S; McIntyre J; Kana B; Stevens W; Sanne I; Richards G; Abdullah F; Mendelson M; Dasoo A; Nel J; Wulfsohn A; Blumberg L; Venter F
    S Afr Med J; 2020 Dec; 111(2):89-94. PubMed ID: 33944712
    [No Abstract]   [Full Text] [Related]  

  • 18. Critical Considerations for COVID-19 Vaccination of Refugees, Immigrants, and Migrants.
    Thomas CM; Osterholm MT; Stauffer WM
    Am J Trop Med Hyg; 2021 Jan; 104(2):433-435. PubMed ID: 33534734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming COVID-19 vaccines into vaccination : Challenges and opportunities for management scientists.
    Dai T; Song JS
    Health Care Manag Sci; 2021 Sep; 24(3):455-459. PubMed ID: 34132977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 Vaccines: Preparing for Vaccination in the Context of Clinical Oncology Care.
    Carr E
    Clin J Oncol Nurs; 2021 Feb; 25(1):76-84. PubMed ID: 33480870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.